Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

desmethylmaprotiline

Known as: 9,10-ethanoanthracene-9(10H)-propylamine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
We describe an analytical procedure for the simultaneous quantification of citalopram (seropram), clozapine (leponex), fluoxetine… Expand
Is this relevant?
2002
2002
From case reports of patients treated with the tetracyclic antidepressant drug maprotiline, it appears that this drug is subject… Expand
Is this relevant?
1992
1992
Compartmental model analysis by simultaneous curve fitting was used to ascertain the pharmacokinetic relationship between… Expand
Is this relevant?
1991
1991
The concentrations of maprotiline (MAP) and its demethylated metabolite desmethylmaprotiline (DMAP) in the serum and specific… Expand
Is this relevant?
1987
1987
Abstract: An investigation was conducted on drug defaulting in 26 depressed patients (11 outpatients and 15 inpatients) treated… Expand
Is this relevant?
1987
1987
Abstract: The relationships between the side effects of maprotiline (MPT) andthe serum concentration of MPT and… Expand
Is this relevant?
1980
1980
Abstract: In conducting the double‐blind controlled study of antidepressants, observations were carried out on the relationship… Expand
Is this relevant?
1977
1977
We describe a gas-chromatographic procedure for estimating therapeutic concentrations of maprotiline, a new tetracyclic… Expand
Is this relevant?